bispecific car t-cell therapy: combining anti-cd19 and cd22 car t-cells
Published 6 years ago • 469 plays • Length 0:45Download video MP4
Download video MP3
Similar videos
-
2:37
efficacy of bispecific cd19/cd22 car t-cells in b-cell malignancies
-
2:36
cd19- and cd22-directed chimeric antigen receptor t-cell therapy in childhood b-cell all
-
2:12
fully human anti-cd19 and cd22 bispecific tandem car-t
-
2:32
phase i study of cd22-targeted car-t therapy in patients with cd19-negative b-all
-
1:21
anti-cd22 car t-cell therapy for all: trial update, utility for salvage and cd19 status
-
3:34
humanized versus murinized cd19/cd22 car-t cell therapy for r/r b-cell lymphoma
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
3:23
phase i study of cd22 car-t therapy in patients with lbcl who have relapsed after cd19 car-t therapy
-
2:17
the role of car t-cell therapy for treating myeloma in the era of bispecific antibodies
-
4:47
cd19 car t-cells for adults
-
2:27
the potential of car t-cell therapy in combination with antibodies for the treatment of all
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
4:24
key questions in the field of cd19 car t-cell therapy
-
3:18
evaluating dual-targeting cd19/22 car-t cells in patients with r/r all
-
2:01
advances in cd22/cd19 car-t sequential therapy
-
1:19
sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
-
4:23
new cd22 car t-cells for pediatric r/r b-all are highly effective
-
4:05
risk factors to predict post-cd19 car-t cell therapy outcomes in patients with lbcl
-
1:27
car t-cells in all: an overview